Trump’s H-1B Visa Fee Dashes Indian Workers’ American Dreams
Big Take Asia1 Okt 2025

Trump’s H-1B Visa Fee Dashes Indian Workers’ American Dreams

President Donald Trump’s H-1B visa fee has sent shockwaves through India’s workforce, which makes up roughly 70% of recipients.

On today's Big Take Asia Podcast, host K. Oanh Ha and Bloomberg’s Sankalp Phartiyal unpack how the policy could disrupt careers, reshape global talent flows and shatter the American dream for tens of thousands of workers.

Read more: Why Trump Is Charging a $100,000 Fee for H-1B Visas
Trump’s $100,000 Visa Targets a $280 Billion India Success Story

Further listening: India Won’t Stop Buying Russian Oil. Now It’s Paying the Price.

Watch, from Originals: How an Army of Middlemen Game the US Work Visa System

See omnystudio.com/listener for privacy information.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(159)

China’s New Message to Its Billionaires: Pay Up

China’s New Message to Its Billionaires: Pay Up

China is ramping up an ongoing effort to shore up local government budgets and fund AI data centers with tax revenue from its richest citizens. Billionaires across the country are seeing bills hit the...

29 Sep 13min

US-China AI Race to Take Center Stage at Trump-Xi Meeting

US-China AI Race to Take Center Stage at Trump-Xi Meeting

As Chinese President Xi Jinping makes his first visit to Washington in over a decade, trade and the AI race will likely dominate talks with Donald Trump. On today’s Big Take Asia podcast, host K. Oanh...

22 Sep 16min

Japan Hikes Rates, Reshaping Carry Trade

Japan Hikes Rates, Reshaping Carry Trade

It’s been a big week for central banks around the world. Yet among the flurry of rate decisions, the Bank of Japan’s move stands out. After decades of near-zero interest rates, policymakers are bettin...

18 Sep 16min

Big Pharma Needs New Drugs. China Has Them

Big Pharma Needs New Drugs. China Has Them

American pharma giants are increasingly turning to Chinese labs to discover, test and develop cutting-edge drugs. On today’s Big Take Asia podcast, Bloomberg’s Amber Tong and Robert Langreth join Oanh...

15 Sep 17min

Is the US AI Reckoning an Opportunity for China?

Is the US AI Reckoning an Opportunity for China?

“The people building AI earnestly believe that it could kill us all by the end of the decade.” An X post by a former employee of both OpenAI and Anthropic went viral this week and is prompting big que...

10 Sep 15min

How India Is Training the Robots of the Future

How India Is Training the Robots of the Future

Tens of thousands of workers in India are wearing head-mounted cameras to record their every move, helping train humanoid robots to perform everyday human tasks. On today’s Big Take Asia podcast, Bloo...

8 Sep 17min

Deadly Flooding in Nepal Highlights Asia’s Climate Vulnerability

Deadly Flooding in Nepal Highlights Asia’s Climate Vulnerability

Hundreds of hydropower workers remain missing in Nepal after a glacial collapse caused catastrophic flooding. The disaster laid bare the rising climate risks across Asia and the danger of building in ...

2 Sep 16min

How Two-Minute Microdramas Became a Billion-Dollar Industry

How Two-Minute Microdramas Became a Billion-Dollar Industry

Microdramas — mini soap operas designed to be watched on your phone — have become one of the fastest-growing forms of entertainment in the world. On today’s Big Take Asia podcast, host K. Oanh Ha spea...

25 Aug 20min

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
rss-penger-polser-og-politikk
e24-podden
rss-skravla-gar
rss-borsmorgen-okonominyhetene
rss-pa-konto
pengepodden-2
finansredaksjonen
livet-pa-veien-med-jan-erik-larssen
pengesnakk
lederpodden
morgenkaffen-med-finansavisen
utbytte
liberal-halvtime
rss-orjasater
tid-er-penger-en-podcast-med-peter-warren
rss-markedspuls-2
okonomiamatorene
rss-impressions-2